Number | Date | Country | Kind |
---|---|---|---|
2-218543 | Aug 1990 | JPX |
Filing Document | Filing Date | Country | Kind | 102e Date | 371c Date |
---|---|---|---|---|---|
PCT/JP91/01100 | 8/16/1991 | 2/19/1993 | 2/19/1993 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO92/03444 | 3/5/1992 |
Number | Name | Date | Kind |
---|---|---|---|
4479947 | Christensen | Oct 1984 | |
4654331 | Christensen | Mar 1987 | |
5036063 | Lattrell et al. | Jul 1991 | |
5116832 | Ishiguro et al. | May 1992 |
Number | Date | Country |
---|---|---|
0039 477 | Nov 1981 | EPX |
0146 626 | Jul 1985 | EPX |
0 199 446 | Oct 1986 | EPX |
0252 885 | Jan 1988 | EPX |
0273 747 | Jul 1988 | EPX |
0275 002 | Jul 1988 | EPX |
0295 100 | Dec 1988 | EPX |
2 220 203 | Jan 1990 | GBX |
Entry |
---|
Bioreversible Carriers in Drug Design: Theory and Application, Pergamon Press, 1987, pp. 13-16, Hans Bundgaard, "Design of Bioreversible Drug Derivatives and the Utility of the Double Prodrug Concept". |
Chem. Pharm. Bull. vol. 38, No. 4, 1990, pp. 1077-1078, I. Miyauchi, et al., "Studies on Penem and Carbapenem. II. An Improved Synthesis of Orally Active Penem Antibiotic (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-2-(2-fluoroethylthio)-6-{(1R)-1-Hydroxyethyl}penem-3-Carboxylate". |